1.17000 EUR
0.04
3.54%
Last update Dec 12, 7:31 PM CET
Market closed
Day range
1.14000
1.20000
Previous close
1.13000
Open
1.18000
Access this stock data via API
Subscribe
InMed Pharmaceuticals Inc.
1.17
0.04
3.54%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 954.6K 1.1M 1.1M 947.5K
Cost of revenue 611.0K 620.5K 925.5K 554.7K
Gross profit 343.6K 491.5K 149.7K 392.8K
Operating expense
Research & development 495.7K 96.1K 775.3K 903.7K
Selling general and admin 1.3M 1.9M 1.1M 1.3M
Other operating expenses
Operating income -1.5M -1.6M -1.8M -1.9M
Non operating interest income
Income 79.9K 44.1K 14.1K 26.0K
Expense 17.0K 0 299.6K
Other income expense -48.6K 18.9K -18.9K -40.7K
Pretax income -1.5M -1.5M -1.8M -2.2M
Tax provision 0 0 0
Net income -1.5M -1.5M -1.8M -2.2M
Basic EPS -0.4 -1.9 -3.6
Diluted EPS -0.4 -1.9 -3.6
Basic average shares 3.4M 934.0K 602.2K
Diluted average shares 3.4M 934.0K 602.2K
EBITDA -1.3M -1.4M -1.7M -1.7M
Net income from continuing op. -1.5M -1.5M -1.8M -2.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 56 minutes

07:03
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).